Main menu

F2G is a world-leading UK and Austrian based biotech company, focused on the discovery and development of novel therapies to treat life threatening invasive fungal infections. Our goal is to bring to market novel antifungal agents which are differentiated from the existing agents in terms of mechanism of action. Globally, there is an unmet medical need for therapies that are active against resistant infections and also against pathogens which have been difficult to treat historically.

Find us

Contact us

F2G Ltd
Lankro Way
United Kingdom
M30 0LX

Telephone | +44 (0)161 785 1270
Fax | +44 (0)161 785 1273
email |

Registered in England and Wales. Company Registration No. 03578625, VAT Reg No. 712680645.